Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
Khloe S. Gordon(Massachusetts Institute of Technology), Michael E. Birnbaum(Ragon Institute of MGH, MIT and Harvard), Brian A. Joughin(Massachusetts Institute of Technology), Caleb R. Perez(École Polytechnique Fédérale de Lausanne), Angela Q. Zhang(Harvard University Press), Yash Agarwal(Allen Institute), Catherine Koch(Centre National de la Recherche Scientifique), Douglas A. Lauffenburger(Harvard University), Alina Starchenko(Massachusetts Institute of Technology), Taeyoon Kyung(Allen Institute), Darrell J. Irvine(Howard Hughes Medical Institute), Michael T. Hemann(Allen Institute), Yunpeng Liu(Shenyang Institute of Automation), Azucena Ramos(Massachusetts Institute of Technology), Patrick V. Holec(Allen Institute)
Cited by 65
Related Papers
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Clonal dynamics of native haematopoiesis
|Nature|2014|838
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
|Nature Biotechnology|2018|641
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
|Clinical Cancer Research|2018|551
Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules
|Molecular & Cellular Proteomics|2005|547